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Abstract
A new staging system for osteoradionecrosis of the mandible has been retrospectively applied to a group of 31 
patients. In this system clinicoradiographic signs and symptoms are incorporated in a simplified manner. For im-
aging purposes the use of plain radiographs such as periapical films and panoramic radiographs is recommended, 
mainly because of their readily availability.
The presented staging system seems well reproducible, facilitating the comparison of study groups dealing with 
the various issues of osteoradionecrosis of the mandible. It is yet to be evaluated whether the presently proposed 
staging system is useful for management purposes.
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Introduction
Osteoradionecrosis (ORN) of the jaws is a relatively 
rare but serious complication in patients who have been 
irradiated in the head-and-neck region. Its onset is usu-
ally after the first year of irradiation. There are several 
hypotheses on the etiology and pathogenesis of ORN. 
Since ORN rarely arises in the maxilla most studies are 
related to ORN of the mandible. Management is cum-
bersome and varies from a conservative approach with 
or without the use of antibiotics and/or hyperbaric oxy-
gen (HbO) treatment to surgery. In an attempt to pre-
vent the disease much attention is paid to elimination of 
potential odontogenic inflammatory foci prior to radio-
therapy and, in case of surgical dental procedures after 
radiotherapy, to the prophylactic use of antibiotics and 
peri-operative HbO treatment.
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ORN has been defined in various ways. Wong et al. 
defined ORN as “a slow-healing radiation induced 
ischemic necrosis of bone with associated soft tissue 
necrosis of variable extent occurring in the absence of 
local primary tumour necrosis, recurrence or metastatic 
disease” (1). Chranovic et al. suggested to add to this 
definition a minimum period of bone exposure of three 
months (2). Store and Boyson defined ORN as “radio-
logical evidence of bone necrosis within the radiation 
field, where tumour recurrence has been excluded” (3). 
The National Cancer Institute defined ORN as “a disor-
der characterized by a necrotic process occurring in the 
bone of the mandible”.
In most of the reported cases of ORN no clear diagnos-
tic criteria have been mentioned. Instead, the diagnostic 
criteria of ORN have often more or less been included 
in a staging system. In fact, numerous attempts have 
been made to stage the disease (2,4-10). 
The aim of the present study is to evaluate the value of a 
new staging system, based on a combination of 1) clini-
coradiographic findings, and 2) symptoms, such as pain 
and presence or absence of oral and/or cutaneous fistu-
las, in  patients suffering from ORN of the mandible.
Patient and Methods
For the purpose of this study ORN has been defined as 
“radiation induced necrosis of bone”. A diagnosis of 
ORN was rendered  in the presence of exposed bone, 
with or without changes on a plain radiograph such as a 
periapical film or panoramic radiograph, having exclud-
ed the presence of tumour tissue, either being a second 
primary or a recurrence. For the purpose of this study 
a definitive diagnosis of ORN has been made in case of 
presence of exposed bone for at least one month.
In the period 2005-2010 a total of 50 consecutive pa-
tients with ORN of the mandible have been registered 
in the database of the VU University Medical Center 
in Amsterdam, the Netherlands and retrospectively 
evaluated. Nineteen patients were excluded because of 
recurrent disease (n=10) or incomplete clinical and ra-
diographic documentation (n=9). As a result 31 patients 
were included, 27 men and four women. The age at the 
time of the diagnosis of ORN varied from 42 years to 83 
years, the mean age being 63 years. 
Management of the patients with ORN ranged from ob-
servation, the use of various types of antibiotics pre-
scribed in various dosages and routes of administration 
(orally or systemically), and various surgical procedures 
with or without peri-operative HbO treatment. In dental 
implant surgery in patients who had previously received 
more than 50 Gy irradiation, peri-operative HbO treat-
ment was routinely given (20 sessions preoperatively 
and 10 sessions postoperatively). Since the focus of this 
study is on the evaluation of a new staging system of 
ORN rather than on reporting treatment results, no de-
tailed data on treatment modalities will be provided.
End-points of the staging procedure were 1) clinically 
resolved condition for a duration of at least one year, 2) 
segmental resection, 3) death, or 4) end of follow-up.
The staging system is depicted in table 1. In this sys-
tem clinicoradiographic signs and symptoms are incor-
porated. Staging has been performed at baseline and at 
various time intervals after the diagnosis of ORN has 
been established. In case of doubt between two stages 
the lower stage has been allotted.
The design of this retrospective study adheres to the 
code for proper use of human material of the Dutch Fed-
eration of Biomedical Scientific Societies (http://www.
federa.org).
Stage 0: Exposure of mandibular bone for less than one month; no 
distinct changes on plain radiographs (panoramic radiograph or 
periapical film). 
Stage I: Exposure of mandibular bone for at least one month; no 
distinct changes on plain radiographs (panoramic radiograph or 
periapical film). Asymptomatic otherwise, e.g. no pain or presence of 
cutaneous fistulas (I A), or symptomatic, e.g. pain or presence of 
cutaneous fistulas (I B). 
Stage II: Exposure of mandibular bone for at least one month; distinct 
changes present on plain radiographs (panoramic radiograph or 
periapical film), but not involving the lower border of the mandible. 
Asymptomatic otherwise, e.g. no pain or presence of cutaneous fistulas 
(II A), or symptomatic, e.g. pain or presence of cutaneous fistulas (II 
B).
Stage III: Exposure of mandibular bone for at least one month; distinct 
changes on plain radiographs (panoramic radiograph or periapical 
film), involving the lower border of the mandible, irrespective of any 
other signs and symptoms. 
Note: In case of doubt about the presence and/or extent of 
radiographical bone involvement, the lower stage should be allotted.
Table 1. Staging system for osteoradionecrosis of the mandible.
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Results
The results of the staging procedure are depicted in table 2. 
Twelve patients were staged as stage I, showing exposure 
of mandibular bone without distinct changes on plain radi-
ographs (Fig. 1),  15 patients were staged as stage II, show-
ing distinct radiographic changes on plain radiographs but 
not extending into the lower border of the mandible (Fig. 
2), and five patients were staged as stage III at the time of 
the diagnosis of ORN,  showing radiographic involvement 
of the lower border of the mandible (Fig. 3).
The mean follow-up period of the entire group of pa-
tients was almost 36 months, while the mean interval 
between stage I and stage II and between stage II and 
stage III amounted 12.7 months and 17,2 months, re-
spectively. In seven patients, evolving directly from 
stage I to stage III, apparently  no radiographs at stage 
II had been made. In these cases the mean interval be-
tween stage I and stage III amounted 19,8 months.
In table 3 the reasons for end of follow-up are shown.
No. of 
patients Minimum Maximum Mean 
std. 
deviation
Stage at first diagnosis of ORN 
Stage I  
A
B
n.s.
12
  4 
  3 
  5 
Stage II 
A
B
n.s.
14
  1 
  7 
  6 
Stage III   5 
Follow-up period (months) 0,16 166,5 35,9 34,9 
Interval end of radiotherapy and 
diagnosis of ORN (months) 
Interval between stages (months) 
0,36 82,6 22,5 20,8 
    Interval stage I – stage II   7 1,6 27,7 12,7 10,8 
    Interval stage II – stage III   12 1,2 53,8 17,2 16,1 
Interval stage I – stage III   7 3,8 58,9 19.8 21,7 
Table 2.  Stage at first diagnosis of osteoradionecrosis (ORN) and during follow-up of 31. Patients.
n.s.= not specified in the record.
Fig. 1. Stage I; exposure of mandibular bone (A); no distinct radiographic changes on the panoramic view (B).
   A
B
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Discussion and Conclusions
For reporting purposes it seems advisable to observe a 
minimum time period of bone exposure, e.g. one month, 
before applying a definitive diagnosis of ORN in the ab-
sence of radiographic changes. Within the period of the 
first month the diagnosis ORN can then be regarded as a 
tentative, provisional one. However, when radiographic 
changes are observed already at the first visit of the pa-
tient, there is no need to observe such a period of one 
month before applying a definitive diagnosis of ORN.
In rare cases there may be distinct radiographical bone 
destruction (stages II and III) during follow-up  in the 
absence of clinically exposed mandibular bone, being 
asymptomatic otherwise. In the present study these pa-
tients have been labeled as having stable disease (Ta-
ble 3). In four patients the mandibular bone exposure 
had resolved while the radiographic changes remained 
present to some extent.
It is well appreciated that conventional radiographic 
imaging, such as orthopantomography, may result in 
an underestimation of the extent or severity of ORN. 
Interpretation of possible changes in the midline of the 
mandible can be difficult at times. Also the presence of 
dental implants may hamper proper evaluation of pos-
sible alterations of the surrounding bone. Furthermore, 
there may be a considerable intraobserver and interob-
server variation in the evaluation of periapical films and 
panoramic radiographs. To some extent, these possible 
biases may be minimized by the recommendation to 
downstage the interpretation of the radiographic find-
ings in case of doubt. 
In spite of possibly more informative imaging tools such 
as CT scanning, positron emission tomography (PET), 
MRI, and radionuclide bone scanning, a panoramic ra-
diograph and/or a periapical film is at present still the 
most readily available imaging tool worldwide.
In the paper by Chrcanovic et al. an excellent over-
view is given of the various staging systems of ORN 
that have been proposed in the past (2). Their criticism 
is that some of these systems are based on response to 
treatment and, therefore, can only be used retrospec-
tively. It seems preferable, indeed, to use a system that 
can be used prospectively as was done in the present 
study. Our staging system seems well reproducible, fa-
cilitating the comparison of study groups dealing with 
the various issues of ORN of the mandible. It is yet to 
be evaluated whether this staging system is valuable for 
management purposes.
Fig. 2. Stage II; exposure of mandibular bone (A); distinct involvement of the mandibular bone but not extending into the lower border (B).
Fig. 3. Stage III; extensive osteoradionecrosis of the mandible in-
volving  the lower border.
Number of 
patients percent 
Segmental resection 14 45,2 
Stable or unstable clinical situation, still in follow-up           8 25,8 
Stable clinical situation, end of follow-up 3 9,7 
Deceased 5 16,1 
Lost to follow-up 1 3,2 
Total 31 100,0 
Table 3. Reasons for end of follow-up in patients with osteoradi-
onecrosis (n=31).
 A  B
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